Skip to content

Skip to secondary menu

Jehovah’s Witnesses



Anemia Management

The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer.

Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H.

Source‎: BJU Int 2011;108(10):1582-7.

Indexed‎: PubMed 21443653

DOI‎: 10.1111/j.1464-410X.2011.10173.x

The role of intravenous iron in anemia management and transfusion avoidance.

Auerbach M, Goodnough LT, Picard D, Maniatis A.

Source‎: Transfusion 2008;48(5):988-1000.

Indexed‎: PubMed 18346021

DOI‎: 10.1111/j.1537-2995.2007.01633.x

The medical section of is designed as an informational resource primarily for use by clinicians and other health-care professionals. It provides neither medical advice nor treatment recommendations and does not substitute for an appropriately qualified health-care provider. The clinical literature cited is not published by Jehovah’s Witnesses, but it outlines transfusion-alternative strategies that might be considered. It is the responsibility of each qualified health-care provider to maintain awareness of new information, discuss options for care, and assist patients in making choices in accord with their medical condition, wishes, values, and beliefs. Not all listed strategies are appropriate or acceptable to all patients.

Patients: Always seek the advice of your doctor or other qualified health-care provider regarding medical conditions or treatments. Check with a doctor if you suspect you are ill.

The use of this website is governed by its terms of use.